Questions about Spect
What is Spect?
Spect is a company focused on addressing vision diseases like Diabetic Retinopathy and Glaucoma, which affect millions globally. They aim to provide efficient screening solutions to reduce the burden on eye clinics and prevent preventable blindness. The business operates out of the US and serves a broad audience needing reliable medical product or service solutions.
What do reviewers praise about Spect?
Reviewers consistently praise Spect for having a user-friendly website, exceptional customer service, and high-quality products. Many users specifically mention that the website getspect.com is easy to navigate and that the support team is top-notch. These positive themes appear across multiple reviews from different dates.
How does Spect compare with what other news sources say about similar technologies?
News articles from November 2026 report on SPECT/BT devices being installed at Şanlıurfa Şehir Hastanesi, though these are medical imaging devices rather than Spect's specific products. This news highlights the broader context of technology used in vision and health care, which aligns with Spect's mission.
What is the official website of Spect?
The official website of Spect is getspect.com.
How is Spect rated on Trustburn?
On Trustburn, Spect has a rating of 3.9 out of 5 based on 11 reviews.
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
Based on reviews, listing data and the company's website. Verify anything important with the company directly.
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Spect
Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.
- Website
- getspect.com
